1. Ahmadvand M, Noruzinia M, Fard AD, Zohour MM et al (2014) The role of epigenetics in the induction of fetal hemoglobin: a combination therapy approach. Int J Hematol Oncol Stem Cell Res 8:9–14
2. Biancha G, Fiorentini P, Gambari R, Nastruzzi C, Barbieri R, Sessarego M, Ravazzolo R, Garre C (1989) Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction. Exp Hematol 17:859–864
3. Bianchi GL, Romani M, Coviello DA, Garre C, Ravazzolo R, Vidali G, Ajmar F (1986) Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Cancer Res 46:6327–6332
4. Bianchi N, Ongaro F, Chiarabelli C, Gualandi L, Mischiati C, Bergamini P, Gambari R (2000) Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol 60:31–40
5. Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E, Gambari R (2001) Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol 113:951–961